Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2013
Dec. 31, 2012
Current Assets    
Cash and cash equivalents $ 362,597 $ 2,197,555
Marketable securities 14,984 1,598,209
Restricted cash 554,731 553,682
Accounts receivable - project revenue and reimbursable project costs 628,789 601,803
Prepaid expenses & other current assets 448,759 574,590
Total Current Assets 2,009,860 5,525,839
Property Plant and Equipment -net 2,019 17,221
Other Assets    
Patent costs - net 672,405 600,596
Total Assets 2,684,284 6,143,656
Current Liabilities    
Accounts payable and accrued liabilities 282,339 385,223
Total Current Liabilities 282,339 385,223
Commitments and contingencies 0 0
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding 0 0
Common stock, $0.001 par value, 500,000,000 authorized, 12,556,400 shares outstanding and 12,526,240 shares outstanding at September 30, 2013 and December 31, 2012, respectively 12,556 12,526
Additional paid in capital - stock and stock equivalents 72,224,284 71,955,631
Deficit (69,834,895) (66,212,849)
Common stock reserved for issuance, 2,264 shares at December 31, 2012 0 3,125
Total Stockholders' Equity 2,401,945 5,758,433
Total Liabilities and Stockholders' Equity $ 2,684,284 $ 6,143,656